Actively Recruiting
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Led by University of Ulm · Updated on 2019-09-25
5000
Participants Needed
1
Research Sites
572 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
CONDITIONS
Official Title
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
- Age =>18 years
- Written informed consent
You will not qualify if you...
- Papillary cancer
- Neuroendocrine pancreatic tumors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitätsklinikum Ulm
Ulm, Germany
Actively Recruiting
Research Team
T
Thomas Seufferlein, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here